Marc Oliva Highlights Landmark Study for LA-HNSCC Published in NEJM
Marc Oliva, Oncology advisor at Obatica, shared on LinkedIn about a recent paper shared by Ravindra Uppaluri et al. published in The New England Journal of Medicine:
“This is a huge moment for head and neck cancer – most importantly for patients with LA-HNSCC! Thanks to all the patients and families whom so generously participated in this trial.
Grateful to the teams at Catalan Institute of Oncology, Hospital Universitari de Bellvitge and Bellvitge Biomedical Research Institute – IDIBELL for their hard work supporting the conduction of the study at the site.
As an early career head and neck medical oncologist, I feel so so lucky to have lived through this moment and time: there is much more work to do for the field and our patients but today gives us strength and hope to Continue.”
Title: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
Authors: Ravindra Uppaluri, Robert I. Haddad, Yungan Tao, Christophe Le Tourneau, Nancy Y. Lee, William Westra, Rebecca Chernock, Makoto Tahara, Kevin J. Harrington, Arkadiy L. Klochikhin, Irene Braña, Gustavo Vasconcelos Alves, Brett G. M. Hughes, Marc Oliva, Iane Pinto Figueiredo Lima, Tsutomu Ueda, Tomasz Rutkowski, Ursula Schroeder, Paul-Stefan Mauz, Thorsten Fuereder, Simon Laban, Nobuhiko Oridate, Aron Popovtzer, Nicolas Mach, Yevhen Korobko, Diogo Alpuim Costa, Anupama Hooda-Nehra, Cristina P. Rodriguez, R. Bryan Bell, Cole Manschot, Kimberly Benjamin, Burak Gumuscu, Douglas Adkins
Read an article about head and neck cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023